Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease.
Hurabielle C, Sicre de Fontbrune F, Moins-Teisserenc H, Robin M, Jachiet M, Coman T, Dhedin N, Cassius C, Chasset F, de Masson A, Michonneau D, Bagot M, Bergeron A, Socié G, Peffault de Latour R, Bouaziz JD.
Hurabielle C, et al. Among authors: coman t.
Br J Dermatol. 2017 Nov;177(5):e206-e208. doi: 10.1111/bjd.15593. Epub 2017 Oct 22.
Br J Dermatol. 2017.
PMID: 28422274
No abstract available.